COMP <GO>
HBIO vs RPID // RSI-14 & 200D SMA MOMENTUM
Harvard Bioscience Inc. (NASDAQ) VS. Rapid Micro Biosystems Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: HBIO 4
— RPID 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: HBIO
LAST: $8.80 (+4.51%) • MKT CAP: $40.1M
rsi-technicals
64.9
LAST: $0.79 (-1.37%) • MKT CAP: $39.6M
rsi-technicals
36.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HBIO VS. RPID)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HBIO | RPID | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 13.66% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -56.10% | -60.00% | +3.90 | HBIO | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -8.10% | 19.70% | -27.80 | RPID | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | HBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 64.9 | 36.1 | +28.80 | HBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $40.1M | $39.6M | $484.4K | HBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HBIO REV | RPID REV | HBIO GROSS % | RPID GROSS % | HBIO FCF | RPID FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $86.5M | $33.6M | 57.7% | — | $5.5M | -$31.9M |
| FY 2024 | $94.1M | $28.1M | 58.2% | — | -$1.2M | -$45.5M |
| FY 2023 | $112.3M | $22.5M | — | — | $14.0M | -$45.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HBIO // BETA —
RPID // BETA —